Ensign Peak Advisors’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Sell |
532,203
-211,957
| -28% | -$6.89M | 0.03% | 342 |
|
|
2025
Q1 | $28.1M | Buy |
744,160
+158,032
| +27% | +$5.97M | 0.05% | 253 |
|
|
2024
Q4 | $48M | Buy |
586,128
+39,293
| +7% | +$3.22M | 0.09% | 195 |
|
|
2024
Q3 | $62.5M | Buy |
546,835
+84,153
| +18% | +$9.62M | 0.11% | 160 |
|
|
2024
Q2 | $34.9M | Sell |
462,682
-13,018
| -3% | -$983K | 0.06% | 215 |
|
|
2024
Q1 | $32.5M | Buy |
475,700
+114,569
| +32% | +$7.83M | 0.06% | 238 |
|
|
2023
Q4 | $22.7M | Buy |
361,131
+85,345
| +31% | +$5.36M | 0.04% | 282 |
|
|
2023
Q3 | $14.1M | Hold |
275,786
| – | – | 0.03% | 321 |
|
|
2023
Q2 | $13.8M | Buy |
275,786
+26,900
| +11% | +$1.34M | 0.03% | 349 |
|
|
2023
Q1 | $9.33M | Buy |
248,886
+350
| +0.1% | +$13.1K | 0.02% | 425 |
|
|
2022
Q4 | $11.9M | Buy |
248,536
+144,961
| +140% | +$6.95M | 0.03% | 373 |
|
|
2022
Q3 | $2.49M | Buy |
103,575
+28,665
| +38% | +$688K | 0.01% | 712 |
|
|
2022
Q2 | $1.63M | Buy |
74,910
+39,010
| +109% | +$849K | ﹤0.01% | 889 |
|
|
2022
Q1 | $867K | Buy |
35,900
+34,480
| +2,428% | +$833K | ﹤0.01% | 1287 |
|
|
2021
Q4 | $34K | Buy |
+1,420
| New | +$34K | ﹤0.01% | 2161 |
|
|
2021
Q2 | – | Sell |
-20,873
| Closed | -$412K | – | 1846 |
|
|
2021
Q1 | $412K | Hold |
20,873
| – | – | ﹤0.01% | 1625 |
|
|
2020
Q4 | $555K | Buy |
+20,873
| New | +$555K | ﹤0.01% | 1583 |
|